EN DE
Watch Charlotte's Web Holdings Inc for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Charlotte's Web Holdings Inc (CWEB) fair value: what the stock is really worth

As of Nov 10, 2026: fair value (intrinsic value) of Charlotte's Web Holdings Inc stock C$0.29, price C$0.24, upside +21.0%, quality 26 out of 100. Rating: fairly valued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare CA · Based in US · ISIN CA16106R1091

CS Charlotte's Web Holdings Inc logo Thin data Nov 10, 2026

Charlotte's Web Holdings Inc

CWEB · TO
Fairly valued, weak quality

The stock costs 17% less than our calculation considers fair.

Fair value C$0.2904 · Fairly valued
Negative equity (buybacks among others)
Revenue last quarter 15% below a year ago.
Quality 26/100
Weak Growth (revenue 5y −12.1 %/yr in USD)
Loss-making · -73.6% net margin (TTM)
Negative free cash flow
Trails peers (2/7)
Narrow moat 10/100 · thin data
Thin data
Estimate
Watch Charlotte's Web Holdings Inc for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

C$4.21 C$0.0900 Fair Value C$0.2904 Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 10, 2026.

How to read this chart

60‑month range C$0.0900 – C$4.21 · fair‑value band C$0.2178 – C$0.3630 · the C$0.2400 price screens below the C$0.2904 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 10, 2026.

Follow Charlotte's Web Holdings in your weekly email

Every Wednesday you see whether Charlotte's Web Holdings is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Charlotte's Web Holdings, Inc. engages in the farming, manufacturing, marketing, and sale of hemp-derived cannabidiol (CBD) and botanical-based wellness products in the United States.

Show moreShow less

The company offers full-spectrum hemp extract oil tinctures, such as liquid products; gummies; capsules; soft-gels; CBD topical creams and lotions; broad-spectrum botanical CBD; functional mushroom gummies; and pet products.

Its products contain naturally occurring phytocannabinoids, including CBD, cannabichromene (CBC), cannabigerol (CBG), cannabinol (CBN), terpenes, flavonoids, and other beneficial hemp compounds. The company markets its products under the Charlotte's Web, Brightside, CBD Clinic, and CBD Medic brands.

It distributes its products through its e-commerce website, third-party e-commerce websites, distributors, retailers, and healthcare practitioners. The company was formerly known as Stanley Brothers Holdings Inc. and changed its name to Charlotte's Web Holdings, Inc. in July 2018.

Charlotte's Web Holdings, Inc. was founded in 2013 and is headquartered in Louisville, Colorado.

Stock analysis

Charlotte's Web Holdings Inc (CWEB) currently trades at C$0.2400, while our estimate is C$0.2904, so the stock looks roughly fairly valued today (gap 17.4%).

Show more

Valuation

None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Scenario range: C$0.2178 (bear) to C$0.3630 (bull), the price of C$0.2400 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 26/100 (below-average quality), in the Healthcare sector.

Weak Growth: Revenue growth is weak: less than 2 % a year.

Charlotte's Web Holdings Inc reported revenue of $49.9M in FY2025 versus $96.1M in FY2021, a compound −15.1%/yr. Reported net income was −$29.7M in FY2025.

Key figures

Market cap C$63.1M (≈ $44.4M) Micro · P/S ratio 1.80 · EPS (TTM) C$−0.2900 · Net margin −59.6% · Return on equity −97.1% · Return on assets (EBIT) −39.1% (5-year average) · Operating margin −40.2% · Revenue (TTM) $46.8M.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 10 out of 100 (low confidence).

What moves the price

The share trades about 81% below its 52-week high and 100% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −27% fair-value upside, at 21%, CWEB screens cheaper than that median.

Fair Value

Bear C$0.2178 Fair Value C$0.2904 Bull C$0.3630
Price C$0.2400 · Upside +21.0%
Estimate. None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Quality Score breakdown

Overall quality 26/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 24
How much profit the company makes from its sales and capital
Quality Growth 55
Are margins and returns getting better?
Cashflow 0
Do the profits arrive as real cash?
Financial strength 12
Debt, balance sheet and risk of trouble
Investment 100
Does it invest with discipline instead of growing at any price?
Low Volatility 0
How calm the share price moves, does not count
Price momentum 31
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 30
Distance to the 52-week high, does not count
New shares 0
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 6/100
Revenue growth is weak: less than 2 % a year.
Revenue growth 1 year
+0.5%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−12.4%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−12.1%
Start year 2020 (pandemic)
Revenue growth 9 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+14.5%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−53.9% (2020) → −40.6% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Watch CWEB, get fair value alerts →

Compare Charlotte's Web Holdings Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 606 stocks

Beats the industry median on 2/7 measures
Overall it trails its industry peers.
Valuation
Quality Score 26 · Bottom 25%
Fair Value upside +21.0% · Top 25%
Profitability
Return on equity (12 months) Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
Return on assets −39.5% · Bottom 25%
Net margin (12 months) −73.6% · Bottom 25%
Operating margin (12 months) −40.2% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) −15.2% · Bottom 25%
Balance sheet
Debt / equity Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.

Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper

P/B Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
P/S (12 months) 0.95× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)61 · sector 18
FUTURE (revenue growth)0 · sector 25
PAST (return on equity)0 · sector 25
HEALTH (low debt)0 · sector 96
DIVIDEND (yield)0 · sector 31

PAST 0: with negative equity (buybacks among others) return on equity is not meaningfully computable.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Zoetis Inc ZTS $82.46 $113.53 +38% vs CWEB
Jiangsu Hengrui Pharmaceuticals Co 600276 ¥48.55 ¥55.21 +14% vs CWEB
Sun Pharmaceutical Industries Limited SUNPHARMA ₹1,905 ₹1,983 +4% vs CWEB
Haleon plc HLN $9.06 $8.62 −5% vs CWEB
Merck KGaA MRK €149.35 €109.18 −27% vs CWEB
Galderma Group GALD CHF 188.55 CHF 109.80 −42% vs CWEB
Takeda Pharmaceutical Company TAK $20.93 $11.34 −46% vs CWEB
Teva Pharmaceutical Industries Limited TEVA $42.40 $20.74 −51% vs CWEB
Sandoz Group SDZ CHF 83.38 CHF 39.70 −52% vs CWEB
Divi's Laboratories Limited DIVISLAB ₹11,566 ₹1,567 −86% vs CWEB

Explore undervalued stocks

More undervalued Healthcare stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Charlotte's Web Holdings Inc: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Charlotte's Web Holdings Inc Fair Value". https://www.fairvalue-calculator.com/stock/CWEB

Frequently asked questions

Is Charlotte's Web Holdings Inc (CWEB) overvalued or undervalued?
As of Nov 10, 2026, our estimate of fair value is C$0.2904 versus a price of C$0.2400, about +21% upside (fairly valued).
What is the fair value of CWEB?
Our estimate for Charlotte's Web Holdings Inc is C$0.2904 (as of Nov 10, 2026), built from audited fundamentals. The current price: C$0.2400.
What is the quality score of CWEB?
Charlotte's Web Holdings Inc has a Quality Score of 26/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Charlotte's Web Holdings Inc (CWEB)?
Our calculated price target is the estimate of C$0.2904 (as of Nov 10, 2026). Cautious scenario C$0.2178, optimistic scenario C$0.3630. It is an estimate from revenue and assets compared with similar companies, because none of our valuation models currently carries, not an analyst target.
What is the Charlotte's Web Holdings Inc stock forecast for 2026?
Our estimate puts fair value at C$0.2904, about +21% upside versus a price of C$0.2400 (fairly valued). Cautious scenario C$0.2178, optimistic scenario C$0.3630. The calculation is refreshed regularly with new filings.
What is the revenue of Charlotte's Web Holdings Inc (CWEB)?
Charlotte's Web Holdings Inc reported trailing-twelve-month revenue of about $46.8M (latest available figure, as of Nov 10, 2026).
What is the intrinsic value of Charlotte's Web Holdings Inc (CWEB)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Charlotte's Web Holdings Inc it is C$0.2904 per share (as of Nov 10, 2026), against a price of C$0.2400.
Is Charlotte's Web Holdings Inc stock overvalued or undervalued in 2026?
As of Nov 10, 2026, CWEB trades below its calculated fair value: price C$0.2400, fair value C$0.2904, a gap of about +21% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of CWEB?
No. The price is what the market pays today (C$0.2400); the fair value is what the company's own numbers justify (C$0.2904). For Charlotte's Web Holdings Inc the two are C$0.0504 per share apart. That gap is exactly why we show both numbers side by side.
How much is Charlotte's Web Holdings Inc worth?
The market values Charlotte's Web Holdings Inc at about C$63.1M (market capitalisation, as of Nov 10, 2026). Per share that is C$0.2400; our models calculate a fair value of C$0.2904 per share.
What do the bullish and bearish scenarios say about CWEB?
Our models span a range for Charlotte's Web Holdings Inc: cautious scenario C$0.2178, base C$0.2904, optimistic C$0.3630 per share (as of Nov 10, 2026, price C$0.2400). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Charlotte's Web Holdings Inc (CWEB)?
Balance-sheet figures for Charlotte's Web Holdings Inc (as of Nov 10, 2026): negative equity, so no return on equity and no debt-to-equity ratio. They feed the Quality Score of 26/100, which measures business quality independently of the share price.
How far is CWEB from its 52-week high?
Charlotte's Web Holdings Inc trades at C$0.2400, about 81% below its 52-week high of C$1.29 and 100% above the low of C$0.1200 (as of Nov 10, 2026). Distance from the high says nothing about value: that is what the fair value of C$0.2904 is for.
Which stocks are comparable to Charlotte's Web Holdings Inc?
From the same area (Healthcare) we also value Merck KGaA, Takeda Pharmaceutical Company, Galderma Group, Teva Pharmaceutical Industries Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Charlotte's Web Holdings Inc stock attractive at the current price?
The data as of Nov 10, 2026: price C$0.2400, calculated fair value C$0.2904 (+21%), Quality Score 26/100. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
Is it still worth investing in stocks now?
The global stock market currently sits 15.1% above its aggregate fair value. Charlotte's Web Holdings Inc currently trades 17% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Charlotte's Web Holdings Inc (CWEB)?
The closing price on Nov 10, 2026 was C$0.2400. Our estimate is C$0.2904, about +21% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Charlotte's Web Holdings Inc right now?
Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual. The price sits in the lower half of our model range, the side with the larger margin of safety. Read the verdict with care: some models are missing inputs, so the estimate scatters more than usual.

Key figures of Charlotte's Web Holdings Inc

How large is the market capitalisation of Charlotte's Web Holdings Inc (CWEB)?
The market capitalisation of Charlotte's Web Holdings Inc is C$63.1M (≈ $44.4M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Charlotte's Web Holdings Inc (CWEB)?
The price-to-sales ratio of Charlotte's Web Holdings Inc is 1.80 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Charlotte's Web Holdings Inc (CWEB)?
Earnings per share at Charlotte's Web Holdings Inc are C$−0.2900. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Charlotte's Web Holdings Inc (CWEB)?
The net margin of Charlotte's Web Holdings Inc is −59.6% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Charlotte's Web Holdings Inc (CWEB)?
The return on equity (ROE) of Charlotte's Web Holdings Inc is −97.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Charlotte's Web Holdings Inc (CWEB)?
On an EBIT basis the return on assets of Charlotte's Web Holdings Inc is −39.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Charlotte's Web Holdings Inc (CWEB)?
The operating margin of Charlotte's Web Holdings Inc is −40.2% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Charlotte's Web Holdings Inc (CWEB)?
Revenue at Charlotte's Web Holdings Inc is growing −15.2% versus a year earlier (3y avg −12.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Charlotte's Web Holdings Inc (CWEB) generate?
The free cash flow of Charlotte's Web Holdings Inc is −$14.7M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Charlotte's Web Holdings Inc (CWEB) carry?
The net debt of Charlotte's Web Holdings Inc is $56.4M (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Charlotte's Web Holdings Inc in the live analysis

One click puts Charlotte's Web Holdings Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.